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Four pediatric patients are presented in whom profound renal 
failure (hepatorenal syndrome) del"eloped in association with se-
vere end-stage liver disease. All four patients had successful 
orthotopic liver transplantation. Special emphasis is given to the 
preoperative and postoperative renal function in the patients, 
and the criteria used to establish the diagnosis of the hepatorenal 
syndrome are discussed. In the initial work on liver transplan-
tation and reversal of the hepatorenal syndrome, two of the three 
patients recovered renal function but died in the perioperative 
period. l The four patients presented in this report have not only 
had reversal of the hepatorenal syndrome after successful or-
thotopic liver transplantation but have also survived long term. 
The four patients have been followed up for periods ranging 
from 18 months to 4.5 years. Three of the four patients have 
maintained near normal renal function, whereas the fourth patient 
(who had a left nephrectomy for obstruction and sepsis) has had 
a significant decline in renal function. 
ONE OF THE WELL-DOCUMENTED complications of end-stage liver disease is renal failure. The oc-
currence of progressive renal failure in patients 
with severe liver failure has been termed the hepatorenal 
syndrome (HRS). In 1973, Iwatsuki et al. reported three 
adult patients who had reversal of their renal failure after 
successful orthotopic liver transplantation.) Unfortu-
nately, two of these patients died in the perioperative pe-
riod although both had improvement in their renal func-
tion. We present four pediatric patients who not only had 
reversal of their renal failure after successful orthotopic 
liver transplantation but also have survived long term: 
three with stable renal function and one with progressive 
renal impairment. 
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Case Reports 
Selected clinical features of the patients presented below 
are shown graphically in Figures 1 and 2. 
Case J 
A 12.5-year-old, 3D-kg white male was referred to the University of 
Pittsburgh on 8/26/81 for evaluation for liver transplantation. He was 
first hospitalized in Chicago in May 1981 when a diagnosis of Wilson's 
disease was made based on elevated serum and urinary copper levels, a 
low serum ceruloplasm. and elevated copper in a liver biopsy. On ad-
mission to the hospital in Pittsburgh he was cachectic and deeply jaun-
diced with moderate ascites and hepatosplenomegaly. Admission labo-
ratory values included a blood-urea nitrogen (BUN) of 13 mg/dL, serum 
creatinine of 0.5 mg/dL, total bilirubin of 35.8 mg/dL, and a urinary 
sodium of 26 mEqJL. During the next 2 weeks an attempt was made to 
control his ascites and hyponatremia. He became oliguric during this 
period with urinary output falling below 0.78 mL/kgfh. On 9/18/81 the 
BUN was 48 mg/dL, serum creatinine was 3.0 mg/dL, and total bilirubin 
was 26 mg/dL. Nephrology consult recommended volume expansion to 
rule out dehydration and prerenal azotemia. Despite expansion of the 
patient's intravascular volumes with both colloid and crystaloid, there 
was no improvement in the urinary output, the urinary sodium remained 
<10 mEqJL, and the fractional excretion of sodium (FEna) in the urine 
ranged from 0.3-0.6%. The patient required hemodialysis twice before 
transplantation. In addition, he had a pronounced deterioration of his 
neurologic status in the last several days before transplantation and he 
was in stage 3 hepatic coma at the time of operation. On the day preceding 
transplantation, laboratory values included a BUN of 80 mg/dL, serum 
creatinine of 4.0 mg/dL, and total bilirubin of 31.5 mg/dL, and his urinary 
output was 0.29 mL/kg/h. On 9/27/81 he had an II-hour liver trans-
plantation during which his urinary output was 0.19 mL/kg/h and his 
fluid balance was positive 4 L. Over the first 72 hours after operation 
his urinary output gradually increased from 0.18 mL/kg/h to 0.64 mL/ 
kg/h. Over the same period his BUN rose to 102 mg/dL, whereas the 
serum creatinine and total bilirubin levels fell to 2.6 mg/dL and 4.5 mg/ 
dL, respectively. By the seventh postoperative day his urinary output 
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FIG. 1. The urinary 0\ItilIn 
for each of the four patients 
is shown from pretrallSf>la&. 
tation day 16 through 16 day, 
after transplantation. Day 0 
is the day of transplantation 
All four patients demo_ 
oliguria in the immediate 
pretransplantation periOd 
with more profound oli&uria 
in the immediate post trans-
plantation period. All four 
patients demonstrated I 
rapid rise in their urinary 
output over the first 2 weeks 
after transplantation, indi-
cating the recovery of renal 
function in all patients. 
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had increased to 1.99 ml/kg/h with a BUN of 74 mg/dL and serum 
creatmine level of 1.5 mg/dL He did not require dialysis after operation. 
His general recovery was complicated by slow resolution of his neurologic 
dysfunction and problems with adequate oral nutrition. After 2 months 
he was discharged with a BUN of 24 mg/dL. serum creatinine level of 
0.7 mg/dL. and total bilirubin level of 0.6 mg/dL. He has maintained 
stable renal and hepatic function over the 4.5 years since transplantation 
(Table I). 
Case 2 
A 17-year-old. 90-kg white male was transferred to the University of 
Pittsburgh on 5/3/82 for treatment of end·stage liver failure and for 
possible liver transplantation. He was first diagnosed with non·A. non· 
B hepatitis in late 1977. After a course of corticosteroids. jaundice resolved 
as did a similar episode of jaundice in April 1978. In December 1981. 
another episode of jaundice improved but never completely resolved 
following steroid therapy. In March 1982. he was admitted to a univel'Slty 
hospital for spontaneous bacterial peritonitis and poorly controlled ascites. 
Laboratory values obtained on that admission included a BUN of8 mgt 
dL. serum creatinine of 0.8 mg/dl. and total bilirubin of 16 mgtdL He 
was treated with gentamicin and a cephalosporin. and despite persistently 
subtherapeutic gentamicin levels his peritonitis resolved. On 4/25/82 his 
BUN had increased to 59 mg/dl and his serum creatinine level increased 
to 2.4 mg/dL Diuretics were stopped and his intravascular volume was 
expanded with colloid and crystaloid guided by his central venous pressure 
measurements. Despite this therapy his serum creatinine level rose to 
4.5 mg/dl and his urinary sodium level fell from 55 mEq/L on 4/25/ 
82 to 8 mEq/L on 4/27/82. Oliguria ensued and peritoneal dialysis was 
instituted. His mental status also deteriorated. and despite continuous 
peritoneal dialysis his BUN rose to 74 mg/dL and serum creatinine level 
rose to 5.2 mg/dL Urinary sodium rose slightly to 26 mEq/l on 4/30/ 
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FIG. 2. The serum creatinine 
levels for each of the four pa. 
tients is shown from pre· 
transplantation day 16 
through 16 days after trans-
plantation. Day 0 is the day 
of transplantation. The four 
patients demonstrate varying 
levels of serum creatinine 
during the 2 weeks before 
transplantation as three of the 
four patients had dialysis 
during this period (see text for 
details). The recovery of renal 
function in all four patients 
during the first 2 weeks after 
transplantation is illustrated 
by the rapid fall in the serum 
creatinine level experienced 
by all patients during this pe. 
riod. The insen shows the 
serum creatinine level for all 
four patients 2 months after 
transplantation. 
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82 although oliguria persisted and FEna was persistently < 1.0%. He was 
transferred to Pittsburgh, and laboratory values on arrival included a 
BUN of 102 mg/dL and serum creatinine of 15.5 mg/dL. Maximal BUN 
and serum creatinine levels before operation were 204 mg/dL and 19.5 
mg/dL. respectively, whereas urinary output ranged from 0.4 mL/kg/h 
to 0.8 mL/kgfh and FEna ranged from 0.2-0.7% during the 2 weeks 
before transplantation. On 5/10/82 he underwent a 13.5-hour liver 
transplantation during which his urinary output was 0.09 mL/kgfh and 
he had a positive fluid balance of6 L. One day after operation his urinary 
output was 0.13 mL/kgfh and urinary sodium was < IO mEq/L. He 
required hemodialysis twice during the first postoperative week. On 
postoperative day 7 his BUN and serum creatinine levels were 134 mg/ 
dL and 3.6 mg/dL. respectively, his total bilirubin level was 15.8 mgf 
dL. and urinary output was> 1.0 mL/kgfh. By day 14 these values had 
fallen to 47 mg/dL. 1.4 mg/dL. and 9.9 mgfdL. respectively. His post-
operative course was complicated by a bile leak requiring an exploratory 
laporotomy and broad spectrum antibiotics. mild graft rejection, and a 
painful neuntis at the site of his dialysis shunt. These problems resolved 
and he was discharged on 6/24/82 with a BUN of 44 mg/dL. serum 
creatinine level of 1.2 mg/dL. and total bilirubin level of 2.3 mg/dL. He 
had rejectIOn of his first liver and underwent a second liver transplantation 
on 1/6/85. He maintained normal renal function throughout the course 
of his second transplantatIon and has continued to have stable renal 
function over the 4 years of follow-up <Table I). 
Case 3 
A 12.5-year-old. 35-kg white male was transferred on 10/25/83 to the 
University of Pittsburgh for evaluation for liver transplantation. He had 
been diagnosed at the age of 4 years as having alpha-I-antitrypsin defi-
ciency. Since that time he had been hospitalized for a variety of com-
plications of the liver disease including peritonitis, ascites. pleural effu-
sions, hypersplenism. and encephalopathy. On admission in Pittsburgh 
physical examination was remarkable for profound jaundice. cachexia. 
hepatosplenomegaly, and massive ascites. Laboratory values included a 
BUN of 38 mg/dL, serum creatinine of 0.9 mg/dL. total bilirubin of28 
mgfdL, and urinary sodium of 30 mEq/L. After several days in the 
hospital. he was discharged but was readmitted on 1 1/14/83 for control 
of his ascites and again on 12/5/83 for spontaneous bacterial peritonitis. 
During this last hospitalization his BUN and serum creatinine levels 
became elevated. and by 12/14/83 they were 64 mg/dL and 1.7 mgfdL. 
respectively. His urinary output fell from 1.79 mL/kgfh to <1.10 mL/ 
kg/h during this same period. Antibiotics during this period were a first-
generation cephalosporin and ampicillin. Urinary sodium fell from 54 
mEq/L on 12/13/83 to 24 mEqfL on 12/15/83 (no other values are 
available), whereas FEna ranged during the perioperative period from 
0.2-0.4%. Renal consult recommended a fluid challenged to rule out 
dehydration and prerenal azotemia as the cause of the renal dysfunction. 
Despite increasing his central venous pressure to greater than 9 mmHg, 
his renal function did not improve. One day before operation his labo-
ratory values included a BUN of 100 mgfdL, serum creatinine of 2.6 
mg/dL, total bilirubin of 5 1.2 mg/dL, and his urinary output was 0.96 
mL/kgjh. He underwent transplantation on 12/19/83, and during his 
l3-hour operation his urinary output was 0.11 mLlkgfh and he had a 
positive fluid balance of 5 L. By postoperative day four his BUN had 
risen to 166 mg/dL and serum creatinine level had risen to 4.5 mgfdL. 
He required dialysis five times over the first 12 postoperative days despite 
a urinary output that increased from 0.04 mL/kg/h to 0.75 mL/kgfh by 
day 12. By the end of the third postoperative week his BUN and serum 
creatinine levels had decreased to 86 mg/dL and 0.8 mg/dL. respectively. 
On postoperative day 10 he was febrile. and Candida was cultured from 
his urine. Work-up revealed a horseshoe kidney with a left ureteropelvic 
Junction obstruction and hydronephrosis. After a prolonged attempt to 
eradicate his funguria. including the placement of a left nephrostomy 
tube, amphotericin irrigations through the nephrostomy tube and sys-
.... 
TABLE I. Follow-Up Laboratory Values as of June 23. 1986 
Interval from 
Transplant BUN Creatinine Bilirubin 
Case # (years) (mg/dL) (mg/dL) (mg/dL) 
I 4.5 30 1.5 1.7 
2 4.0 24 I.l 1.8 
3 2.3 96 3.2 1.6 
4 1.5 44 1.9 0.8 
temic amphotericin. he underwent a resection of the left portion of the 
horseshoe kidney on 2/23/83. After the procedure he made a rapid re-
covery. and at the time of discharge on 3/7/83 his BUN was 43 mgfdL. 
serum creatinine level was 1.1 mgfdL. and total bilirubin level was 0.8 
mg/dL. Over the past 27 months of follow-up he has remained well but 
has had a significant deterioration of his renal function despite continued 
normal liver function (Table I). 
Case 4 
A 13-year-old. 80-kg white female was transferred to the University 
of Pittsburgh on 10/16/84 for liver transplantation. Approximately I 
month before her transfer she had a fl u-like illness with nausea, vomiting/ 
fever. malaise. and pharyngitis. Several days after the onset of symptoms 
she was seen by her local physician who noted right upper quadrant pain 
and Jaundice (total bilirubin level was 20 mg/dL). The tentative diagnosis 
was hepatitis although serologic tests for hepatitis were negative. She was 
admitted to her local hospital 2 days later. Results of physical examination 
revealed splenomegaly, deep jaundice. and no abnormalities on neuro-
logic examination. Laboratory values included a BUN of 58 mgfdL, 
serum creatinine of 4.8 mg/dL. and total bilirubin of 55.8 mg/dL. The 
patient was transferred to a university hospital where re-evaluation re-
vealed that her renal failure, coagulopathy. and liver failure had all wors-
ened and she was now in stage two hepatic coma. A diagnosis of acute 
Wilson's disease was confirmed by the presence of elevated serum and 
urinary copper levels, low serum ceruloplasm, and high copper levels on 
liver biopsy. Over the next 12 days her condition further deteriorated. 
She had two respiratory arrests requiring mechanical ventilation, do-
pamine, and lidocaine. She became oliguric (urinary output <0.02 mL/ 
kgfh) and was maintained on daily hemodialysis. A liver became available 
for transplantation on 10/16/84 and the patient was transferred to Pitts-
burgh. Preoperative laboratory values included a BUN of 67 mg/dL, 
serum creatinine of 5.9 mgfdL, and total bilirubin of 48 mgfdL. During 
her 18-hour surgery her urinary output was 0.04 mL/kg/h and she had 
a positive fluid balance of 7 L. Over the first 7 days after operation her 
urinary output increased from 0.05 mL/kg/h to 0.29 mL/kg/h. She re-
quired hemodialysis four times during the first 2 postoperative weeks. 
Renal function steadily improved and her Bun was 80 mg/dL and serum 
creatinine level was 2.3 mg/dL by the end of the first postoperative month. 
Her total bilirubin level 1 month after operation was 3.0 mg/dL. This 
recovery took place in the face of a number of complications that occurred 
during the postoperative period. These included two episodes of cutaneous 
herpes requiring two IO-day courses of acyclovir. a bile leak requiring 
operative repair and broad spectrum antibiotics for 14 days, and moderate 
rejection of the hepatic allograft reversed with high-dose steroids. Two 
months after transplantation she was discharged with a BUN of 56 mg/ 
dL. serum creatinine level of 1.1 mg/dL, and total bilirubin level of 1.4 
mgfdL. She was readmitted approximately 3 months later for treatment 
of acute rejection of the hepatic allograft. At that time she had a major 
gastrointestinal hemorrhage as well as a severe episode of rejection. De-
spite these difficulties her renal function remained essentially unchanged 
from the time of her initial discharge and has remained stable during 
the 18 months of follow-up (Table I) . 
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TABLE 2. Criteria Used to Diagnose HRS 
Criteria 
Presence of severe liver disease. 
Absence of primary renal disease. 
Acute or subacute onset of azotemia. 
Relative oliguria with urine output <500 mL/24 h. 
Urinary sodium <10 mEqjL or FEna <1.0%. 
Benign urinary sediment. 
No response to volume expansion or correction of "prerenal" factors. 
Discussion 
HRS was first described by surgeons in the 1930s, and 
since that time it has been the subject of much research 
and speculation.2 One of the major difficulties in the study 
ofthis syndrome has been the lack of universal agreement 
regarding the criteria needed to establish this diagno-
sis.3-S The criteria that we have used to make this diagnosis 
are listed in Table 2. Although not all inclusive, these 
criteria have served as useful guidelines to identify the 
presence of this syndrome in our patients awaiting liver 
transplantation. All of these patients had obvious severe 
end-stage liver failure and would have died in a relatively 
short time had they not undergone a liver transplantation. 
Three patients had deterioration of their liver function 
over several years, whereas Case 4 had acute hepatic fail-
ure. All four patients had profound hyperbilirubinemia 
at. the time oftheir liver transplantation. However, there 
has been no correlation between the level of bilirubin and 
the onset of renal failure. 3 Our experience would tend to 
support this. Many of the patients awaiting liver trans-
plantation have total bilirubin levels that are elevated to 
an even greater degree than the four patients presented, 
and yet many of these patients maintain normal renal 
function. 
All four patients had progressive deterioration of their 
renal function yet, in all four, the urinalysis remained 
/ normal on repeated examinations throughout their pre-
operative hospital course. In Cases 1 and 3, despite long 
histories of progressive liver failure with multiple com-
plications, renal failure developed acutely in less than 2 
weeks. Case 2 also had chronic hepatic failure but expe-
rienced a more gradual onset of renal failure over the 
course of several weeks. Renal failure developed in Case 
4 soon after the onset of acute hepatic failure. Neither the 
duration of the renal failure or length of time with hepatic 
failure nor the time course over which the renal failure 
developed seemed to influence the duration of the renal 
failure after transplantation. 
mappe~ noted the interesting observation that most of 
his 200 patients with HRS entered the hospital with nor-
mal renal function. This was also the case in three of our 
four patients. The Question that remains unanswered is 
whether the HRS results from the events that precipitated 
the hospital admission or results from events that occur 
after the patient is hospitalized. The single most prominer 
factor in our patients appeared to be an acute depletio 
of the intravascular volume. In Case 4 this appeared t 
be secondary to severe emesis. whereas in Cases I and 
it was related to aggressive diuretic therapy to control ~ 
cites. Cases 2 and 3 had episodes of moderately sever 
peritonitis, and Case 2 also had a gastrointestinal hem 
orrhage as another possible precipitating event. Unfor 
tunately no consistent precipitating event(s) has bee: 
identified. As stated by Papper,3 "There are no apparen 
clinical, functional, renal, or hepatic laboratory charac 
teristics that identify those patients with cirrhosis wh( 
will ultimately develop renal failure." 
Just before transplantation, urinary output of these fou 
patients averaged 0.39 mL/kg/h (range: 0.02-0.96). How 
ever, all patients experienced severe oliguria during op 
eration and during the immediate postoperative period 
Iwatsuki et al. 1 reported that the time for recovery of rena 
function in three adult patients was Quite variable. In thi~ 
series, all four patients had a significant return of rena 
function by the end of the second postoperative wee. 
(Figs. 1 and 2). In all cases the recovery of renal functior 
was associated with continued improvement in hepati( 
allograft function. This correlates well with the fact tha: 
in the isolated case reports of spontaneous recovery frorr 
the HRS reported in the literature, the single most im· 
portant factor was improvement in the patients' live: 
function. 3.5- 8 
All four patients received intravenous cyclosporine ~ 
their primary immunosuppressive agent. This drug i~ 
profoundly nephrotoxic, and it is interesting that renal 
function improved and normalized despite the use ofthi~ 
drug. The recovery of renal function also occurred in spite 
of the fact that three of the four patients had significant 
postoperative complications including, in Case 3, a left 
nephrectomy and the use of systemic amphotericin. an-
other potentially nephrotoxic agent. Three of the four pa-
tients have maintained stable renal function during the 
follow-up period, which ranges from 1.5-4.5 years. Case 
3, however, has experienced a gradual deterioration of his 
renal function since his transplantation. possibly second-
ary to damage done to the remaining portion of his horse-
shoe kidney at the time of the partial nephrectomy or 
perhaps secondary to long-term cyclosporine nephrotox-
icity (Table 1). It is clear from the course of our patients 
that after recovery from the HSR there are no long-term 
detrimental effects on renal function. This reaffirms the 
concept that the renal insult in patients with the HSR is 
reversible and that the damaged liver is the source of the 
nephrotoxic "agent." 
The differentiation of the HRS from prerenal azotemia 
or acute tubular necrosis is often Quite difficult. All of the 
patients except Case 4 underwent a deliberate attempt to 
expand their intravascular volume to eliminate dehydra-
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tion or prerenal azotemia as the cause of their deteriorating 
renal function. There was no improvement in any patient 
after this therapy. The attempt to expand the intravascular 
volume in this group of patients must be closely guided, 
as it was in these patients, by the central venous pressure 
measurements. Pulmonary edema is prone to develop in 
these patients even with minimal volume overload. 
One finding believed by most authors to be important 
in the diagnosis of the HRS has been the presence of uri-
nary sodium concentrations of <10 mEq/L. In addition, 
Steiner (\984) and Espinel (1976) noted that patients with 
the HRS had FEna of <1.0%.9.10 All four patients had 
values for urinary sodium excretion within the above lim-
its. A wide range of values was noted in all patients, and 
urinary sodium excretion varied with the stage of the ill-
ness. This further illustrates that no single criterion can 
be exclusively used to make the diagnosis of the HRS. 
Rather. the diagnosis is dependent on both laboratory 
and clinical data that are interpreted in the overall setting 
of the patient's illness. 
The benefit of dialysis in patients with the HRS has 
been controversial. ll - Is and the use of dialysis in patients 
with the HRS has even been claimed to have an adverse 
effect on survivalY In the current series, Cases I, 2, and 
4 had dialysis before transplantation, and no patient ex-
perienced a further deterioration in their clinical status. 
In fact, Case 2 had an increase in urine volume after the 
institution of peritoneal dialysis. Three of the four patients 
required further dialysis treatments after operation before 
the return of adequate renal function. Although there is 
no data to support the routine use of dialysis in patients 
with the HRS, in our unique transplant population the 
use of preoperative dialysis supported three patients until 
a suitable donor liver could be procured, whereas post-
operative dialysis provided support for three patients until 
there was adequate improvement in their intrinsic renal 
function. Therefore, in this unique group of patients with 
the HRS, dialysis was of unquestionable value. 
It is beyond the scope of this paper to discuss the various 
theories that speculate as to the cause of the HRS, and 
the reader is referred to the excellent reviews by Papper, 3 
Metz and Tompkins,S and Conn.4 The major difficulty 
in identifying the cause of this syndrome has been high 
mortality associated with the syndrome, which obviously 
does not allow for comparisons of patients before and 
after recovery from the syndrome. Detailed studies ofliver 
transplant candidates in whom HRS develops and whom 
subsequently undergo transplantation may provide in-
valuable information in the search for the cause of this 
syndrome. 
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